- Tytuł:
- Sickle Cell Disease Gene-editing Therapy Close to FDA Approval: Doctors and regulators are interested in a new treatment that edits a patient's stem cells to produce more fetal hemoglobin, which has been observed to cause red blood cells to not "sickle.".
- Autorzy:
- Temat:
-
SICKLE cell anemia treatment
GENOME editing
UNITED States. Food & Drug Administration - Źródło:
- Hill. 11/15/2023, Vol. 30 Issue 69, p14-15. 2p.
Wiadomości